CIK 0001755237
- Non-accelerated filer
- Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 831895370
- Phone
- +1 781-516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 3,559 shares at $5.12 ($18,222)
- 4 Open-market sale President sold 50,000 shares at an average $2.52 ($125,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Innovation Officer bought 125,000 shares at $1.82 ($227,500)
- 4 Open-market sale Chief Financial Officer sold 3,922 shares at $2.05 ($8,040)
- 4/A Grant or award Chief Executive Officer acquired 221,736 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4/A Grant or award Chief Financial Officer acquired 77,492 shares (grant or award)
- 4 Exercise or conversion Chief Executive Officer acquired 2,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 7 · 134 filings